Inari Medical Inc (Inari) is a medical device company that develops, manufactures and commercializes innovative catheter-based technologies for treating venous thromboembolism (VTE). The company products portfolio includes the ClotTriever and FlowTriever systems, designed to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). Inari products are used by healthcare professionals, including interventional radiologists, cardiologists and vascular surgeons, in catheterization laboratories and interventional suites. It operates in the US, Switzerland, Singapore, Canada, Australia, Brazil, the UK and Ireland. Inari is headquartered in Irvine, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Inari Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Inari Medical Inc Company Overview
- Inari Medical Inc Company Snapshot
- Inari Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Inari Medical Inc - Pipeline Analysis Overview
- Inari Medical Inc - Key Facts
- Inari Medical Inc - Major Products and Services
- Inari Medical Inc Pipeline Products by Development Stage
- Inari Medical Inc Ongoing Clinical Trials by Trial Status
- Inari Medical Inc Pipeline Products Overview
- ClotTriever Thrombectomy System
- ClotTriever Thrombectomy System Product Overview
- ClotTriever Thrombectomy System Clinical Trial
- Crossing Device
- Crossing Device Product Overview
- FlowSaver Blood Return System
- FlowSaver Blood Return System Product Overview
- FlowTriever2 Catheter
- FlowTriever2 Catheter Product Overview
- FlowTriever2 Catheter - Pulmonary Embolism
- FlowTriever2 Catheter - Pulmonary Embolism Product Overview
- FlowTriever2 Catheter - Pulmonary Embolism Clinical Trial
- LimFlow Percutaneous Deep Vein Arterialisation System
- LimFlow Percutaneous Deep Vein Arterialisation System Product Overview
- LimFlow Percutaneous Deep Vein Arterialisation System Clinical Trial
- Recanalization Device
- Recanalization Device Product Overview
- Stent Cleaner Device
- Stent Cleaner Device Product Overview
- Triever16 Curve
- Triever16 Curve Product Overview
- Triever20
- Triever20 Product Overview
- Triever24
- Triever24 Product Overview
- Triever24 Flex Catheter
- Triever24 Flex Catheter Product Overview
- Inari Medical Inc - Key Competitors
- Inari Medical Inc - Key Employees
- Inari Medical Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Inari Medical Inc, Recent Developments
- Jun 13, 2025: LimFlow Receives the Additional FDA 510(k) Clearance for LimFlow ARC
- May 28, 2025: Inari Medical Receives Additional 510(K) Clearance For InThrill Thrombectomy System
- Mar 20, 2025: Inari Medical Receives 510(K) Clearance For FlowTriever2 Catheter
- Feb 20, 2025: LimFlow Receives Additional FDA 510(k) Clearance for LimFlow V-CEIVER (Venous Catheter)
- Dec 02, 2024: Inari Medical Announces Reimbursement Approval for ClotTriever Thrombectomy System in Japan and New Distribution Partnership with Medikit
- Nov 07, 2024: Dr. Pedro Martinez-Clark, Founder of Amavita Heart and Vascular, Partners with LimFlow, an FDA Approved System for Chronic Limb-Threatening Ischemia Patients
- Oct 29, 2024: PEERLESS Results Show Superiority of FlowTriever Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
- Oct 15, 2024: Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial
- Oct 08, 2024: Inari Medical Receives 510(K) Clearance For ClotTriever XL Catheter (41-102)
- Oct 07, 2024: Inari Medical to Announce Third Quarter 2024 Financial Results
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Inari Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- Inari Medical Inc Pipeline Products by Equipment Type
- Inari Medical Inc Pipeline Products by Indication
- Inari Medical Inc Ongoing Clinical Trials by Trial Status
- Inari Medical Inc, Key Facts
- Inari Medical Inc, Major Products and Services
- Inari Medical Inc Number of Pipeline Products by Development Stage
- Inari Medical Inc Pipeline Products Summary by Development Stage
- Inari Medical Inc Ongoing Clinical Trials by Trial Status
- Inari Medical Inc Ongoing Clinical Trials Summary
- ClotTriever Thrombectomy System - Product Status
- ClotTriever Thrombectomy System - Product Description
- ClotTriever Thrombectomy System - DEFIANCE - ClotTriever Thrombectomy System vs. Anticoagulation Alone for Treatment of Deep Vein Thrombosis
- Crossing Device - Product Status
- Crossing Device - Product Description
- FlowSaver Blood Return System - Product Status
- FlowSaver Blood Return System - Product Description
- FlowTriever2 Catheter - Product Status
- FlowTriever2 Catheter - Product Description
- FlowTriever2 Catheter - Pulmonary Embolism - Product Status
- FlowTriever2 Catheter - Pulmonary Embolism - Product Description
- FlowTriever2 Catheter - Pulmonary Embolism - PEERLESS II: RCT of FlowTriever vs. Anticoagulation Alone in Pulmonary Embolism
- LimFlow Percutaneous Deep Vein Arterialisation System - Product Status
- LimFlow Percutaneous Deep Vein Arterialisation System - Product Description
- LimFlow Percutaneous Deep Vein Arterialisation System - Percutaneous Deep Vein Arterialization for the Treatment of Late-stage Chronic Limb-threatening Ischemia: The PROMISE II Trial
- LimFlow Percutaneous Deep Vein Arterialisation System - Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial
- LimFlow Percutaneous Deep Vein Arterialisation System - Percutaneous Deep Vein Arterialization Post-market Study
- LimFlow Percutaneous Deep Vein Arterialisation System - Percutaneous Deep Vein Arterialization Post-market Study
- Recanalization Device - Product Status
- Recanalization Device - Product Description
- Stent Cleaner Device - Product Status
- Stent Cleaner Device - Product Description
- Triever16 Curve - Product Status
- Triever16 Curve - Product Description
- Triever20 - Product Status
- Triever20 - Product Description
- Triever24 - Product Status
- Triever24 - Product Description
- Triever24 Flex Catheter - Product Status
- Triever24 Flex Catheter - Product Description
- Inari Medical Inc, Key Employees
- Inari Medical Inc, Subsidiaries
- Glossary
- Inari Medical Inc Pipeline Products by Equipment Type
- Inari Medical Inc Pipeline Products by Development Stage
- Inari Medical Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Teleflex Inc
- AngioDynamics Inc
- Philips North America LLC
- Boston Scientific Corp
- Penumbra Inc
- Abbott Laboratories
